Akari Therapeutics Plc (NASDAQ:AKTX)

About the company

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

10

CEO

Clive Stuart Richardson

Exchange

NASDAQ

Website

http://akaritx.com

$NoneM

Total Revenue

10

Employees

$36.18M

Market Capitalization

-2.01

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382409.47 82729.00 6.14 22.29 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 153076.50 23087.00 51.95 26.98 23.97
AbbVie, Inc. ABBV 147435.40 34057.00 -23.60 17.58 24.65
Bristol Myers Squibb Co. BMY 113009.51 31006.00 2.74 96.08 3.08
Repligen Corp. RGEN 6331.14 286.00 6.07 275.87 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4248.64 137.00 3.32 -9.25 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3748.16 1.00 34.65 -5.73 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1639.59 None 5.33 -26.30 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1590.96 30.00 5.67 -22.64 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Akcea Therapeutics, Inc. AKCA 1360.91 341.00 2.79 -48.38 -8.59
Tricida, Inc. TCDA 1310.26 None 6.74 -6.20 None
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Arcutis Biotherapeutics, Inc. ARQT 1184.00 None 5.05 -18.93 None
Odonate Therapeutics, Inc. ODT 1121.14 None 9.18 -9.96 None
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Aprea Therapeutics, Inc. APRE 714.00 None 6.32 -21.12 None
Applied Therapeutics, Inc. APLT 712.58 14.00 4.60 -14.46 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 645.58 19.00 59.83 -23.21 -151.34
Amneal Pharmaceuticals, Inc. AMRX 621.98 1679.00 4.28 -2.86 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 554.61 None 5.57 -9.64 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
Biospecifics Technologies Corp. BSTC 466.97 40.00 3.79 19.97 61.80
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Fulcrum Therapeutics, Inc. FULC 419.75 1.00 7.07 -6.08 None
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 379.08 6.00 4.15 -4.13 None
Relmada Therapeutics, Inc. RLMD 373.32 0.00 5.57 -31.19 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 321.75 None 7.61 -4.93 None
Urovant Sciences Ltd. UROV 302.10 None -5.36 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 300.30 4.00 9.48 -3.74 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
Spero Therapeutics, Inc. SPRO 260.49 12.00 3.43 -3.20 -656.72
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 252.32 542.00 0.86 -8.30 -5.77
Gritstone Oncology, Inc. GRTS 227.88 4.00 2.04 -2.18 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 219.60 12.00 2.43 -6.78 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
Sutro Biopharma, Inc. STRO 184.92 41.00 3.51 -3.03 -148.06
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Protara Therapeutics, Inc. TARA 173.70 None 2.61 -11.26 None
Liquidia Technologies, Inc. LQDA 173.14 8.00 13.57 -3.51 -602.17
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 138.32 119.00 3.53 -4.41 -27.05
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
PhaseBio Pharmaceuticals, Inc. PHAS 126.73 2.00 2.35 -2.65 None
NeuBase Therapeutics, Inc. NBSE 123.62 None 51.94 -2.77 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
EyePoint Pharmaceuticals, Inc. EYPT 79.57 26.00 5.62 -1.62 -196.30
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Checkpoint Therapeutics, Inc. CKPT 70.80 2.00 6.10 -3.05 -949.53
Baudax Bio, Inc. BXRX 67.32 None -1.83 -0.96 None
Navidea Biopharmaceuticals, Inc. NAVB 67.15 1.00 -49.38 -6.08 -65.13
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 58.32 192.00 1.01 -0.36 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 52.89 20.00 1.59 -2.80 -51.58
Menlo Therapeutics, Inc. MNLO 50.17 2.00 4.22 -0.54 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
Oncternal Therapeutics, Inc. ONCT 33.54 3.00 4.30 -1.33 -225.89
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Aileron Therapeutics, Inc. ALRN 32.20 None 4.42 -1.21 None
Acer Therapeutics, Inc. ACER 31.30 3.00 2.28 -1.20 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.97 None 1.33 -0.47 None
Novus Therapeutics, Inc. NVUS 7.35 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.95 5.00 1.62 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Stock Alert: Akari Therapeutics Up 7%

6d ago, source: Nasdaq

(RTTNews) - Shares of Akari Therapeutics, Plc (AKTX) gained over 7% on Wednesday morning. The company announced the ...

Akari Therapeutics Enters into a Securities Purchase Agreement for up to $30 Million with Aspire Capital Fund, LLC

6d ago, source: YAHOO!

Akari Therapeutics, Plc (“Akari” or the “Company”) (AKTX), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflam ...

Akari Therapeutics Announces Appointment of Chief Financial Officer

7d ago, source: Benzinga.com

NEW YORK and LONDON, July 01, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc ("Akari" or the "Company") (NASDAQ:AKTX), a biopharmaceutical company focused on the development and ...

BRIEF-Akari Therapeutics Enters Into A Securities Purchase Agreement For Up To $30 Mln With Aspire Capital Fund

7d ago, source: Reuters

AKARI THERAPEUTICS ENTERS INTO A SECURITIES PURCHASE AGREEMENT FOR UP TO $30 MILLION WITH ASPIRE CAPITAL FUND, LLC * AKARI THERAPEUTIC ...

Akari Therapeutics Announces Appointment of Chief Financial Officer

7d ago, source: Stockhouse

NEW YORK and LONDON, July 01, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (“Akari” or the “Company ...

Stock Alert: Akari Therapeutics Up 7%

6d ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net (RTTNews) - Shares of Akari Therapeutics, Plc (AKTX) gained over 7% on Wednesday morning. The company announced the ...

BRIEF-Akari Therapeutics Enters Into A Securities Purchase Agreement For Up To $30 Mln With Aspire Capital Fund

6d ago, source: Reuters

AKARI THERAPEUTICS PLC - HAS ENTERED INTO A SECURITIES PURCHASE AGREEMENT OF UP TO $30 MILLION WITH ASPIRE CAPITAL FUND, LLC * AKARI THERAPEUTICS PLC - IN AGREEMENT, ASPIRE CAPITAL TO PURCHASE UP ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.